Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European Randomised Phase 3 Study to Assess the Efficacy and Safety of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance

NCT01310894 is registered in ClinicalTrials.gov with Steba Biotech S.A. as lead sponsor.

NCT NCT01310894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European Randomised Phase 3 Study to Assess the Efficacy and Safety of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance
Lead sponsor
Steba Biotech S.A.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
August 31, 2015
Enrollment
413 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer